…
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -180.57M | -73.34M | -12.57M | -15.43M | - |
| Net income | -179.76M | -60.11M | -14.97M | -19.51M | - |
| Selling general administrative | 81.59M | 80.00M | 19.34M | 16.03M | - |
| Gross profit | -10.41M | 0.88M | 11.46M | 11.11M | - |
| Reconciled depreciation | 20.09M | 10.63M | 5.12M | 4.07M | - |
| Ebit | -187.43M | -99.39M | -15.74M | -10.40M | -1.19M |
| Ebitda | -48.23M | -88.80M | -10.30M | -4.16M | - |
| Depreciation and amortization | 139.20M | 10.59M | 5.44M | 6.24M | - |
| Non operating income net other | 8.59M | 26.89M | 5.58M | - | - |
| Operating income | -187.43M | -99.39M | -15.74M | -10.40M | - |
| Other operating expenses | 177.16M | 158.14M | 63.07M | 42.75M | - |
| Interest expense | 112.25M | 0.76M | 2.43M | 3.48M | 0.00M |
| Tax provision | -0.81M | -13.23M | 0.00M | 4.08M | - |
| Interest income | - | - | 0.35M | 0.34M | - |
| Net interest income | -1.72M | -0.76M | -2.08M | -3.13M | - |
| Non recurring | 63.49M | - | - | - | - |
| Income tax expense | -0.81M | -13.23M | 2.40M | 4.08M | 0.05M |
| Total revenue | 53.22M | 58.75M | 47.33M | 32.34M | - |
| Total operating expenses | 113.53M | 100.27M | 27.19M | 21.51M | - |
| Cost of revenue | 63.63M | 57.87M | 35.88M | 21.24M | - |
| Total other income expense net | 6.87M | 26.05M | 3.16M | -5.03M | - |
| Net income from continuing ops | -179.76M | -60.11M | -12.57M | -19.51M | - |
| Net income applicable to common shares | -179.76M | -60.11M | -12.57M | -19.51M | 0.21M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 712.27M | 838.60M | 546.20M | 144.57M | - |
| Intangible assets | 80.94M | 84.66M | 1.80M | 2.05M | - |
| Other current assets | 5.22M | 4.74M | 3.09M | 0.42M | - |
| Total liab | 334.66M | 338.33M | 107.30M | 128.00M | - |
| Total stockholder equity | 377.61M | 500.26M | 438.90M | 16.58M | - |
| Deferred long term liab | - | 1.40M | - | - | - |
| Other current liab | 4.80M | 18.78M | 9.22M | 9.72M | 5.91M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.00M | - |
| Retained earnings | -298.65M | -118.89M | -62.50M | -49.93M | -29.57M |
| Other liab | 0.86M | 11.23M | 1.25M | 2.50M | - |
| Good will | 0.00M | 62.65M | - | - | - |
| Other assets | 33.28M | 15.51M | 15.84M | 30.88M | 39.22M |
| Cash | 62.79M | 286.49M | 377.58M | 6.26M | - |
| Total current liabilities | 25.29M | 43.48M | 50.49M | 34.28M | 12.64M |
| Current deferred revenue | 0.20M | 0.21M | 2.46M | 4.58M | - |
| Net debt | 251.03M | 0.83M | -293.82M | 96.81M | - |
| Short term debt | 5.31M | 3.69M | 28.20M | 11.86M | - |
| Short long term debt | 1.97M | 0.36M | 25.20M | 9.28M | - |
| Short long term debt total | 313.82M | 287.32M | 83.76M | 103.07M | - |
| Other stockholder equity | 676.25M | 619.14M | 501.40M | 66.50M | - |
| Property plant equipment | 453.95M | 335.42M | 126.18M | 92.41M | 54.66M |
| Total current assets | 125.07M | 340.36M | 402.38M | 19.24M | 18.04M |
| Net tangible assets | 377.61M | 352.96M | 437.10M | 14.52M | 24.86M |
| Net receivables | 24.31M | 24.56M | 8.07M | 5.52M | 6.96M |
| Long term debt | 286.40M | 260.93M | 31.39M | 73.78M | - |
| Inventory | 32.74M | 24.57M | 13.64M | 7.04M | 4.04M |
| Accounts payable | 14.98M | 20.79M | 10.61M | 8.12M | 1.14M |
| Accumulated other comprehensive income | - | - | -19.63M | -15.54M | - |
| Common stock total equity | 0.01M | 0.01M | 0.01M | 0.00M | - |
| Retained earnings total equity | -298.65M | -118.89M | -58.78M | - | - |
| Non currrent assets other | 33.08M | 15.51M | 15.84M | 30.88M | - |
| Non current assets total | 587.20M | 498.24M | 143.82M | 125.33M | - |
| Capital lease obligations | 25.45M | 26.03M | 27.18M | 20.02M | - |
| Long term debt total | - | 260.93M | 31.39M | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -18.04M | -336.17M | -38.26M | -49.09M | - |
| Change to liabilities | -7.72M | -0.19M | -1.13M | 3.21M | 2.94M |
| Total cashflows from investing activities | -182.48M | -336.17M | -38.26M | -49.09M | 2.81M |
| Net borrowings | 21.61M | 213.08M | 2.61M | 54.03M | -7.48M |
| Total cash from financing activities | 21.75M | 306.20M | 422.68M | 53.50M | -0.45M |
| Change to operating activities | -0.99M | -5.94M | 2.86M | 7.02M | -0.75M |
| Net income | -179.76M | -60.11M | -12.57M | -19.51M | 0.21M |
| Change in cash | -222.57M | -92.93M | 370.62M | 2.73M | 2.68M |
| Begin period cash flow | 286.97M | 379.90M | 9.28M | 6.55M | - |
| End period cash flow | 64.40M | 286.97M | 379.90M | 9.28M | 6.55M |
| Total cash from operating activities | -61.84M | -62.96M | -13.80M | -1.67M | 0.32M |
| Issuance of capital stock | - | - | 32.52M | 8.75M | - |
| Depreciation | 20.09M | 10.63M | 5.12M | 4.07M | 3.54M |
| Other cashflows from investing activities | 0.04M | -150.76M | 0.01M | - | - |
| Dividends paid | - | 0.89M | - | 48.25M | - |
| Change to inventory | -11.17M | -9.80M | -6.60M | -2.99M | -0.86M |
| Change to account receivables | -3.06M | -10.84M | -1.60M | 2.19M | -2.65M |
| Sale purchase of stock | -0.24M | -0.89M | 441.62M | -4.60M | - |
| Other cashflows from financing activities | 23.73M | 336.03M | 392.10M | 112.82M | -0.03M |
| Change to netincome | 112.34M | 12.96M | -0.82M | 3.58M | -3.04M |
| Capital expenditures | 164.49M | 185.41M | 38.27M | 36.56M | 5.61M |
| Change receivables | -0.54M | -10.84M | -1.60M | - | - |
| Cash flows other operating | 2.46M | -7.56M | -3.90M | - | - |
| Cash and cash equivalents changes | -222.57M | -92.93M | 370.62M | - | - |
| Change in working capital | -19.32M | -28.87M | -7.18M | 8.68M | - |
| Stock based compensation | 56.96M | 55.27M | 3.65M | 5.27M | - |
| Other non cash items | 61.01M | -26.65M | 2.46M | -4.32M | - |
| Free cash flow | -226.32M | -248.37M | -52.06M | -38.23M | - |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| LIN Linde plc Ordinary Shares |
3.57 0.68% |
526.06 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.02 0.05% |
42.57 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
2.55 1.20% |
214.85 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-1.50 0.43% |
349.89 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
140 Industrial Boulevard, Bainbridge, GA, United States, 39817
229 243 7075
271
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen E. Croskrey | CEO & Chairman | 1961 |
| Mr. Michael Smith | Chief Operating Officer | 1969 |
| Mr. Phillip D. Van Trump | Chief Science & Technology Officer | 1977 |
| Mr. Scott C. Tuten | Chief Marketing & Sustainability Officer | 1976 |
| Mr. John A. Dowdy III | Sr. VP of Financial Planning & Analysis | 1973 |
| Mr. Michael A. Hajost | Chief Financial Officer | 1964 |
| Russ Zukowski | VP of Corp. Fin. | NA |
| Mr. Stephen Albert Martin Esq. | Corp. Sec. & Chief Legal Officer | 1969 |
| Ms. Deborah McRonald | Chief Corp. Devel. Officer | NA |
| Mr. Anthony L. Austin | Chief Human Resource Officer | 1958 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.